Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

81.08 +0.34 (+0.42%)
Official Closing Price Updated: 7:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,867,013
Open 80.63
Bid (Size) 80.70 (1)
Ask (Size) 81.50 (3)
Prev. Close 80.74
Today's Range 80.02 - 81.71
52wk Range 67.13 - 131.10
Shares Outstanding 608,300,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Looking Into Edwards Lifesciences's Recent Short Interest
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023
 
Via Benzinga

Performance

YTD
+9.17%
+9.17%
1 Month
+3.27%
+3.27%
3 Month
+10.42%
+10.42%
6 Month
-8.72%
-8.72%
1 Year
-27.32%
-27.32%

More News

Read More
Expert Ratings for Edwards Lifesciences
Via Benzinga
Interview With David Rolfe of Wedgewood Partners
Via The Motley Fool
Edwards Lifesciences Stock Jumps After Beating Fourth-Quarter Views
Via Investor's Business Daily
Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
Via Benzinga
What 8 Analyst Ratings Have To Say About Edwards Lifesciences
Via Benzinga
A Preview Of Edwards Lifesciences's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
Via Benzinga
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 4
Via Talk Markets
Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023
Via Benzinga
Expert Ratings for Edwards Lifesciences
Via Benzinga
15 Analysts Have This to Say About Edwards Lifesciences
Via Benzinga
2 Top Dividend Growth Stocks to Buy in February
Via The Motley Fool
Earnings Scheduled For January 31, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
Via Benzinga
Amazon To Rally Around 29%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
2 Smartest Tech Stocks to Buy in 2022 and Beyond
Via The Motley Fool
Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'
Via Benzinga
JPMorgan To Rally Around 17%? Here Are 10 Other Price Target Changes For Tuesday
Via Benzinga
Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
Via Benzinga
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Via MarketBeat
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
Via Benzinga
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Via MarketBeat
Topics Death
Exposures COVID-19 Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.